New 3-Tier System for Targeted Mass Spectrometry Assays
Price: $ 19.99
4.6(254)
An NIH workshop developed a “fit-for-purpose”, 3-tier approach to identifying goals and characteristics of targeted MS assays to help identify the level of accuracy
A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases - eBioMedicine
TUBE-based Mass Spec Proteomics
Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites
Sample multiplexing for targeted pathway proteomics in aging mice
Cancers, Free Full-Text
Targeted N-Glycan Analysis with Parallel Reaction Monitoring Using a Quadrupole-Orbitrap Hybrid Mass Spectrometer
CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis - Laboratory Investigation
Targeted proteomics for cancer biomarker verification and validation - IOS Press
Overview of Tier 1 and Tier 2 Thresholds for the % Difference between
Rapid Diagnostics Testing Study Roundup
LCMS-8050 : SHIMADZU (Shimadzu Corporation)
Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody–drug conjugates - Chemical Science (RSC Publishing) DOI:10.1039/D1SC02973H